[86] documented that RG7834, a novel oral HBV gene expression inhibitor, could lessen the amounts of viral proteins and lower viremia. RG7834 is a small-molecule compound belonging to the dihydroquinolizinones chemical class much like RNAi but as a result of a different mechanism.Moreover, a combination of antiviral medication with the immune-modul